NANOBIOTIX S.A. SP.ADR (5NRA) — Working Capital to Net Assets Ratio
NANOBIOTIX S.A. SP.ADR (5NRA) has a Working Capital to Net Assets ratio of -6.2% as of December 2025. Working capital of €5.24 Million (current assets of €62.75 Million minus current liabilities of €57.51 Million) is measured against net assets of €-84.48 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See NANOBIOTIX S.A. SP.ADR defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
NANOBIOTIX S.A. SP.ADR Working Capital to Net Assets (2021–2025)
This chart shows how NANOBIOTIX S.A. SP.ADR's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at -6.2%, reflecting working capital of €5.24 Million against net assets of €-84.48 Million EUR. For the complete balance sheet picture, see NANOBIOTIX S.A. SP.ADR (5NRA) total assets.
Annual Working Capital to Net Assets for NANOBIOTIX S.A. SP.ADR (2021–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for NANOBIOTIX S.A. SP.ADR from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Explore long-term investment intensity of NANOBIOTIX S.A. SP.ADR to see how much of total assets are deployed in long-term investments.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -6.2% | €5.24 Million | €-84.48 Million | €62.75 Million | €57.51 Million | ▼ -2.4 pp |
| 2024 | -3.9% | €2.53 Million | €-65.70 Million | €61.47 Million | €58.94 Million | ▲ +2027.9 pp |
| 2023 | -2031.8% | €37.47 Million | €-1.84 Million | €87.34 Million | €49.87 Million | ▼ -1978.5 pp |
| 2022 | -53.3% | €14.42 Million | €-27.05 Million | €52.36 Million | €37.94 Million | ▼ -263.2 pp |
| 2021 | 209.8% | €56.22 Million | €26.79 Million | €93.06 Million | €36.84 Million | — |